Works matching Abbott Pharmaceuticals Corp.
Results: 42
560-P: Reimagining the Assessment of Diabetes Distress in Type 2 Diabetes.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-560-P
- By:
- Publication type:
- Article
256-OR: Substantial Cardiovascular Risk Reduction with Icosapent Ethyl Regardless of Diabetes Status or BMI: REDUCE-IT BMI.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-256-OR
- By:
- Publication type:
- Article
185-OR: Longitudinal Changes in KidneyIntelX and Association with Progressive Decline in Kidney Function in the CANVAS Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-185-OR
- By:
- Publication type:
- Article
131-LB: The Impact of Canagliflozin on the Risk of Neuropathy Events: Results from the CREDENCE Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-131-LB
- By:
- Publication type:
- Article
129-LB: Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex in the CREDENCE Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-129-LB
- By:
- Publication type:
- Article
1205-P: Baricitinib Inhibition of Jak/STAT Pathway Changed Immune Composition in Adipose Tissue and Improved Metabolism in Diet-Induced Obese Mice.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-1205-P
- By:
- Publication type:
- Article
83-LB: Adherence and Persistence in Patients with T2D Initiating Once-Weekly vs. Once-Daily Injectable GLP-1RA in U.S. Clinical Practice: STAY Study.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-83-LB
- By:
- Publication type:
- Article
747-P: Improved Treatment Perceptions with IGlarLixi vs. Premix Insulin in Type 2 Diabetes (T2D) Uncontrolled on Basal Insulin (BI) + Oral Antihyperglycemic Drugs (OADs): Patient-Reported Outcomes (PROs) of the SoliMix Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-747-P
- By:
- Publication type:
- Article
71-OR: Youth with Type 1 Diabetes and Their Parents Report Improved Quality of Life with the Omnipod 5 Automated Insulin Delivery System.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-71-OR
- By:
- Publication type:
- Article
709-P: Improved Satisfaction and Perceived Usability with the Omnipod 5 Automated Insulin Delivery System Compared with Prior Therapy.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-709-P
- By:
- Publication type:
- Article
704-P: Adults with Type 1 Diabetes Report Improved Quality of Life with the Omnipod 5 Automated Insulin Delivery System.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-704-P
- By:
- Publication type:
- Article
672-P: The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Twelve-Month Data Analysis.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-672-P
- By:
- Publication type:
- Article
144-LB: Medicaid Expansion and Utilization of Antihyperglycemic Therapies.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-144-LB
- By:
- Publication type:
- Article
129-OR: Abnormal Mitochondrial Activity in Pain Processing Regions of the Brain in Painful Diabetic Peripheral Neuropathy.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-129-OR
- By:
- Publication type:
- Article
85-LB: Freestyle Libre System Use Associated with Reduction in Acute Diabetes Events and All-Cause Hospitalizations in Patients with Type 2 Diabetes without Bolus Insulin.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-85-LB
- By:
- Publication type:
- Article
84-LB: HbA1c Reduction after Initiation of the FreeStyle Libre System in Type 2 Diabetes Patients on Long-Acting Insulin or Noninsulin Therapy.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-84-LB
- By:
- Publication type:
- Article
78-LB: HbA1c Reduction Associated with a FreeStyle Libre System in People with Type 2 Diabetes Not on Bolus Insulin Therapy.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-78-LB
- By:
- Publication type:
- Article
733-P: Postprandial Glucose Variability in People with Type 1 Diabetes Is Individual and Impacted by Physiological and Clinical Parameters.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-733-P
- By:
- Publication type:
- Article
68-OR: Dramatic Drop in Ketoacidosis Rate after FreeStyle Libre System Initiation in Type 1 and Type 2 Diabetes in France, Especially in People with Low Self-Monitoring of Blood Glucose (SMBG): A Nationwide Study.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-68-OR
- By:
- Publication type:
- Article
533-P: Predicting Treatment Response in Painful Diabetic Neuropathy Using Magnetic Resonance Brain Imaging.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-533-P
- By:
- Publication type:
- Article
526-P: Urine Tricarboxylic Acid Cycle Organic Anions and Progression of Diabetic Kidney Disease.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-526-P
- By:
- Publication type:
- Article
4-LB: Substantial Cardiovascular Benefit from Icosapent Ethyl in Patients with Diabetes: REDUCE-IT DIABETES.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-4-LB
- By:
- Publication type:
- Article
491-P: Renal Hemodynamic Dysfunction and Neuropathy in Long-Standing Type 1 Diabetes (T1D): Results from the Canadian Study of Longevity in T1D.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-491-P
- By:
- Publication type:
- Article
1127-P: Real-World Clinical Outcomes Associated with Canagliflozin 100mg and with Intensification of SGLT2 Inhibitor Therapy Switching to Canagliflozin 300mg in Patients with Type 2 Diabetes Mellitus: The Real-WECAN Study.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1127-P
- By:
- Publication type:
- Article
2220-PUB: Renal Outcomes Associated with Canagliflozin 100mg and with Intensification of SGLT2 Inhibitor Therapy Switching to Canagliflozin 300mg in Patients with Type 2 Diabetes Mellitus in a Real-World Setting: The Renal-WECAN Study.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-2220-PUB
- By:
- Publication type:
- Article
21-OR: Implementation of an Intensive Telehealth Intervention for Rural Patients with Uncontrolled Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-21-OR
- By:
- Publication type:
- Article
1827-P: Higher Glucagon-Like Peptide-1 Response and Lower Beta-Cell Glucose Sensitivity Are Associated with Increased Glycemic Variability among Individuals with Prediabetes.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1827-P
- By:
- Publication type:
- Article
1630-P: Glycemic Burden and Treatment Effectiveness in Young-Onset Type 2 Diabetes.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1630-P
- By:
- Publication type:
- Article
1512-P: Incidence of Type 1 and Type 2 Diabetes in Hong Kong: Analysis of the Hong Kong Diabetes Surveillance Database.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1512-P
- By:
- Publication type:
- Article
1298-P: Unique Patterns of Racial/Ethnic Disparities among Vulnerable Young Adults with Type 1 Diabetes.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1298-P
- By:
- Publication type:
- Article
803-P: Modifiable Diabetes-Specific Factors and Glycemic Control in Economically Vulnerable and Racial/Ethnic Minority Young Adults with Type 1 Diabetes.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-803-P
- By:
- Publication type:
- Article
542-P: One-Year eGFR Decline Rate Predicts Renal Outcome in High-Risk Japanese Patients with Hypercholesterolemia and Diabetic Retinopathy.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-542-P
- By:
- Publication type:
- Article
533-P: Association of Serum Branched-Chain Amino Acids with Kidney Function Decline in Type 2 Diabetes: The Hong Kong Diabetes Register.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-533-P
- By:
- Publication type:
- Article
421-P: Documentation of Heart Failure in Outpatients with Type 2 Diabetes and Evidence of Volume Overload: A Report from the Diabetes Collaborative Registry (DCR).
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-421-P
- By:
- Publication type:
- Article
343-LB: The Type 2 Diabetes-Associated Lipid Binding Protein STARD10 Controls Insulin Secretory Granule Biogenesis.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-343-LB
- By:
- Publication type:
- Article
2459-PUB: Clinical Characteristics and Management of Patients with Type 1 Diabetes—A National Population-Based Spanish Study (SED1).
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2459-PUB
- By:
- Publication type:
- Article
2368-PUB: Cost Analysis of a Flash Glucose Monitoring System in Type 1 Diabetes Vulnerable Patients, in Spain.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2368-PUB
- By:
- Publication type:
- Article
1061-P: Effect of the Omnipod<sup>®</sup> Insulin Management System on Glycemic Control in Adults with Type 1 Diabetes Previously Treated with MDI or CSII.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1061-P
- By:
- Publication type:
- Article
1020-P: Semaglutide-Induced Weight Loss Is Associated with Improved Health-Related Quality of Life and Treatment Satisfaction.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1020-P
- By:
- Publication type:
- Article
In brief.
- Published in:
- Nature, 2007, v. 446, n. 7134, p. 363, doi. 10.1038/446363a
- Publication type:
- Article
Sertindole (Serlect)...
- Published in:
- Brown University Psychopharmacology Update, 1998, v. 9, n. 4, p. 5
- Publication type:
- Article
Market watch: Upcoming market catalysts in Q4 2012.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 740, doi. 10.1038/nrd3856
- By:
- Publication type:
- Article